SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1352458507084269v1
14/3/300    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Koch, M.
Right arrow Articles by De Keyser, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, M.
Right arrow Articles by De Keyser, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Progression in familial and nonfamilial MS

Marcus Koch*, Maarten Uyttenboogaart, Marco Heerings, Dorothea Heersema, Jop Mostert, and Jacques De Keyser

Department of Neurology, University Medical Center Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands

* To whom correspondence should be addressed.


   Abstract

Objective

To investigate whether the timing of secondary or primary progression is different betweenpatients with familial and nonfamilial multiple sclerosis (MS).

Methods

Information on the family history of 313 patients with MS was taken from our prospectivehospital-based database. We used Kaplan–Meier analyses and Cox regression models to evaluatedifferences between familial and nonfamilial MS in several endpoint measures. We investigated the riskof developing secondary progression in all patients with a relapsing–remitting disease onset, thelength of the relapsing–remitting phase and age at onset of progression in patients with secondaryprogressive MS and the age at disease onset in patients with primary progressive MS (PPMS).

Results

Among the primary progressive patients, those with familial MS had a significantly youngerage at disease onset than patients with nonfamilial MS (mean 33.04 years versus mean 37.73 yearsin nonfamilial MS, P _ 0.02). There were no significant differences between familial and nonfamilialMS patients in any other investigated measure.

Conclusions

Familial MS appears related to the time of disease onset in PPMS. Patients withfamilial PPMS may be an important patient group for future genetic research in MS.

Key Words: familial MS; hereditary MS; multiple sclerosis; progression

First published on January 21, 2008, doi:10.1177/1352458507084269

Multiple Sclerosis 2008;14:300.

A more recent version of this article appeared on April 1, 2008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement